Effectiveness of non-pharmacological therapies on cognitive function in patients with dementia—A network meta-analysis of randomized controlled trials

Frontiers in Aging Neuroscience

Neuroscience

Chengjiang Liu¹  Fang Wang²  Zeyi Song³  Haifeng Qu³  Guangxin Luo⁴  Xiaojing Wang⁴  Junqiu Zhang⁴  Ying Wang⁴  Fujia Gao⁵ 

[1] Department of General Medicine, Affiliated Anqing First People’s Hospital of Anhui Medical University, Anqing, China;Department of Psychology, The Fourth People’s Hospital of Wuhu, Wuhu, China;School of Clinical Medicine, North China University of Science and Technology, Tangshan, China;School of Public Health, North China University of Science and Technology, Tangshan, China;School of Public Health, North China University of Science and Technology, Tangshan, China;Hebei Province Key Laboratory of Occupational Health and Safety for Coal Industry, School of Public Health, North China University of Science and Technology, Tangshan, China;

关键词: dementia;    cognitive;    non-pharmacological therapy;    network meta-analysis;    randomized controlled trials;   

DOI  :  10.3389/fnagi.2023.1131744

 received in 2022-12-30, accepted in 2023-02-13,  发布年份 2023

来源: Frontiers

【 摘 要 】

ObjectiveNon-pharmacological therapies (NPTs) have received increasing attention from researchers as a category of treatment to improve cognitive impairment in patients with dementia because of their fewer side effects. In this study, photobiomodulation (PBM), enriched environment (EE), exercise therapy (ET), computerized cognitive training (CCT), and cognitive stimulation therapy (CST) were selected to compare the effects of NPTs that improve dementia by quantifying information from randomized controlled trials (RCTs).MethodsWe did a systematic review and network meta-analysis. We searched PubMed, Embase, Cochrane Central Register of Controlled Trials (CENTRAL), China National Knowledge Infrastructure Database, Wan Fang Database, Chinese Biomedical Literature Database, Web of Science, and VIP Database from the time of database creation to 1 August 2022. Two investigators independently screened the literature, extracted information, and assessed the RCTs’ quality with the Cochrane Collaboration Network Risk of Bias 2.0. Network meta-analysis was performed using R language (X64 version 4.1.3) and STATA 17.0.ResultsWe identified 1,268 citations and of these included 38 trials comprising 3,412 participants. For improving dementia, the results of the network meta-analysis showed that compared with the control group (CON), PBM (SMD = 0.90, 95% CI: 0.43–1.37), EE (SMD = 0.71, 95% CI: 0.02–1.41), ET (SMD = 0.42, 95% CI: 0.16–0.68), and CST (SMD = 0.36, 95% CI: 0.11–0.62) were significantly different (P < 0.05); There was no significant difference in CCT (SMD = 0.41, 95% CI: −0.07–0.88) (P > 0.05). The ranked results showed that PBM has more potential to be the best intervention (P = 0.90). In addition, there was a significant difference between PBM and CST in improving cognitive function (SMD = 0.54, 95% CI: 0.00; 1.08, P < 0.05).ConclusionIn this study, NPTs have excellent potential to improve cognition in people with dementia, and PBM may have more significant benefits in improving cognition than the other four NPTs.Systematic review registrationhttps://www.crd.york.ac.uk/prospero/, identifier CRD42022363746.

【 授权许可】

Unknown   
Copyright © 2023 Luo, Zhang, Song, Wang, Wang, Qu, Wang, Liu and Gao.